Page last updated: 2024-08-24

loxiglumide and Biliary Tract Cancer

loxiglumide has been researched along with Biliary Tract Cancer in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Itho, M; Matsuda, S; Ogura, Y; Sasaki, H; Shimomura, M; Tanigawa, K1

Other Studies

1 other study(ies) available for loxiglumide and Biliary Tract Cancer

ArticleYear
Inhibitory effect of loxiglumide (CR 1505), a cholecystokinin receptor antagonist, on N-nitrosobis(2-oxopropyl) amine-induced biliary carcinogenesis in Syrian hamsters.
    World journal of surgery, 2002, Volume: 26, Issue:3

    Topics: Adenocarcinoma, Papillary; Animals; Autoradiography; Biliary Tract Neoplasms; Carcinogens; Cholecystectomy, Laparoscopic; Cricetinae; Disease Models, Animal; Duodenostomy; Female; Hormone Antagonists; Mesocricetus; Nitrosamines; Proglumide; Radiography; Receptors, Cholecystokinin

2002